Feeds
Coffee seems to be good for you. Or at least it's not bad, say researchers who led the largest-ever study of coffee and health.
One of life's simple pleasures just got a little sweeter. After years of waffling research on coffee and health, even some fear that java might raise the risk of heart disease, a big study finds the opposite: Coffee drinkers are a little more likely to live longer. Regular or decaf doesn't matter.
Test-tube babies have higher rates of birth defects, and doctors have long wondered: Is it because of certain fertility treatments or infertility itself? A large new study from Australia suggests both may play a role.
New research suggests that long-term use of any type of hormones to ease menopause symptoms can raise a woman's risk of breast cancer.
Provocative new research might help explain why black women are so much more likely than whites to develop and die from cervical cancer: They seem to have more trouble clearing HPV, the virus that causes the disease.
Older patients with clogged heart arteries may have a little lower death risk over time if they get bypass operations instead of angioplasty and stents to fix the problem, new research suggests.
New research gives clear proof that weight-loss surgery can reverse and possibly cure diabetes, and doctors say the operation should be offered sooner to more people with the disease — not just as a last resort.
Doctors say it is unlikely that former Vice President Dick Cheney got special treatment when he was given a new heart at age 71 that thousands of younger people also were in line to receive.
Officials at drugmaker Merck & Co. say they will take more time to decide what to do about an experimental blood thinner that gave disappointing results in a second big study.
They are questions already being debated: Did the soldier suspected of killing Afghan villagers have post-traumatic stress disorder, or PTSD? And did the people who sent him back to war after he was injured properly determine he was mentally fit to return?
A big study of men in Europe gives mixed results about prostate cancer screening that may do little to change minds about its value.
Scientists are reporting what could be very bad news for efforts to customize cancer treatment based on each person's genes.
A heart device might save your life but leave you miserable. That awful possibility is the reason for new advice urging doctors to talk more honestly with people who have very weak hearts and are considering pumps, pacemakers, new valves or procedures to open clogged arteries.
In a story Feb. 25 about the cost of cancer care, The Associated Press misspelled the name of a lung cancer drug made by Pfizer Inc. It is Xalkori, not Zalkori.
A warning to men considering a pricey new treatment for prostate cancer called proton therapy: Research suggests it might have more side effects than traditional radiation does.
Surprising results from two new studies may reopen debate about the value of Avastin for breast cancer. The drug helped make tumors disappear in certain women with early-stage disease, researchers found.
The government wants to start regulating face and hand transplants just as it does now with kidneys, hearts and other organs, with waiting lists, a nationwide system to match and distribute body parts and donor testing to prevent deadly infections.
Unhappy with today's health care? Think of what it was like to be sick 200 years ago.
Avastin, the blockbuster drug that just lost approval for treating breast cancer, now looks disappointing against ovarian cancer, too. Two studies found it did not improve survival for most of these patients and kept their disease from worsening for only a few months, with more side effects.
Doctors were mostly hoping to prevent complications and relapses when they gave young women a medicine to keep their bones strong during breast cancer treatment. Seven years later, they found it did more than that: The bone drug improved survival, as much as many chemotherapies do.
Breast cancer experts are cheering what could be some of the biggest advances in more than a decade: two new medicines that significantly delay the time until women with very advanced cases get worse.
Women concerned about breast cancer should worry less about cellphones and hair dyes and worry more about weighing or drinking too much, exercising too little, using menopause hormones and getting too much radiation from medical tests. So says a new report on environmental risks by a respected panel of science advisers.
New research casts doubt on a popular treatment for breast cancer: A week of radiation to part of the breast instead of longer treatment to all of it.
It's true — apple juice can pose a risk to your health. But not necessarily from the trace amounts of arsenic that people are arguing about.
A woman's heart breaks more easily than a man's.
Log In | Register
